FDA 510(k)
FDA class 1
Substantially Equivalent
🇺🇸 United States
LIAISON Testosterone xt
K Number: K201908
·
Decision Oct 15, 2020
Classifications
1
FEI Numbers
60
Registration Numbers
60
Same Product Code
87
Applicant Total
22
Review Days
98
Basic Information
- Device Name
- LIAISON Testosterone xt
- K Number
- K201908
- Device Class
- FDA class 1
- Clearance Type
- Special
- Regulation Number
- 862.1680
- Medical Specialty
- Clinical Chemistry
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- DiaSorin Inc.
- Date Received
- July 9, 2020
- Decision Date
- October 15, 2020
- Product Code
- CDZ
- Advisory Committee
- Clinical Chemistry
- Review Advisory Committee
- CH
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| CDZ | Radioimmunoassay, Testosterones And Dihydrotestosterone | FDA class 1 | Clinical Chemistry |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (CDZ), ordered by most recent decision date.
IDS-iSYS Free Testosterone
FDA 510(k)
FDA Class 1
·Clinical Chemistry
Access SHBG
FDA 510(k)
FDA Class 1
·Clinical Chemistry
Access Testosterone
FDA 510(k)
FDA Class 1
·Clinical Chemistry
Elecsys Testosterone II
FDA 510(k)
FDA Class 1
·Clinical Chemistry
ACTIVE® Free Testosterone RIA
FDA 510(k)
FDA Class 1
·Clinical Chemistry
ADVIA Centaur Testosterone II (TSTII), ADVIA Centaur SHBG
FDA 510(k)
FDA Class 1
·Clinical Chemistry
Other Clearances by DiaSorin Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K231214 | LIAISON VZV IgG HT, LIAISON Control VZV IgG HT | Oct 27, 2023 | Substantially Equivalent |
| K223403 | LIAISON Anti-HAV; LIAISON XS | Dec 9, 2022 | Substantially Equivalent |
| K213858 | LIAISON Calprotectin, LIAISON Q.S.E.T. Device Plus | Jul 26, 2022 | Substantially Equivalent |
| K213936 | LIAISON MeMed BV, LIAISON MeMed BV Control Set | Jul 14, 2022 | Substantially Equivalent |
| K202573 | LIAISON Lyme IgM, LIAISON Lyme IgM Control Set, LIAISON Lyme Total Antibody Plus | Feb 18, 2021 | Substantially Equivalent |
| K202574 | LIAISON Lyme IgG, LIAISON Lyme IgG Control Set, LIAISON Lyme Total Antibody Plus | Feb 18, 2021 | Substantially Equivalent |
| K210272 | LIAISON Anti-HAV | Feb 9, 2021 | Substantially Equivalent |
| K193532 | LIAISON Anti-HAV Assay | Mar 2, 2020 | Substantially Equivalent |
| K193051 | LIAISON Lyme Total Antibody Plus, LIAISON Lyme Total Antibody Plus Control Set | Jan 29, 2020 | Substantially Equivalent |
| K192046 | LIAISON XL Zika Capture IgM II and LIAISON XL Zika Capture IgM II Control Set | Oct 28, 2019 | Substantially Equivalent |